Invention Grant
- Patent Title: Crystalline forms of therapeutic compounds and uses thereof
-
Application No.: US17197702Application Date: 2021-03-10
-
Publication No.: US11713323B2Publication Date: 2023-08-01
- Inventor: Elizabeth Enlow , Minh Ngoc Nguyen , Winston Z. Ong
- Applicant: Kala Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: Kala Pharmaceuticals, Inc.
- Current Assignee: Kala Pharmaceuticals, Inc.
- Current Assignee Address: US MA Arlington
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Michelle Glasky Bergman
- The original application number of the division: US14530092 2014.10.31
- Main IPC: C07D491/107
- IPC: C07D491/107 ; A61K9/00 ; A61K9/10 ; A61K9/14 ; A61K47/10 ; A61K9/50 ; A61K31/517
Abstract:
Described herein are certain crystalline forms of Compound 3, as well as pharmaceutical compositions employing the crystalline forms. Also provided are particles (e.g., nanoparticles) comprising such crystalline forms or pharmaceutical compositions. In certain examples, the particles are mucus penetrating particles (MPPs). The present invention further relates to methods of treating or preventing diseases using crystalline forms or pharmaceutical compositions.
Public/Granted literature
- US20210355133A1 CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF Public/Granted day:2021-11-18
Information query
